Topics: Optimising effectiveness of existing prescription drugs for major diseases with the use of biomarkers | New methods for the effective use of real-world data / synthetic data in regulatory decision-making / health technology assessment
Deadline: 21.04.2022
HORIZON-HLTH-2022-TOOL-11-01:
Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers (RIA)
♦ Cross-cutting priorities: Clinical Studies, SSH
HORIZON-HLTH-2022-TOOL-11-02:
New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment (RIA)
♦ Cross-cutting priorities: Clinical Studies, SSH, EOSC and FAIR data
